Streptomyces filamentosus Mutant DKB108 for High-Yield Daptomycin Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Wild-type Streptomyces filamentosus strains exhibit low daptomycin productivity, making them unsuitable for high-yield antibiotic production, and existing methods only achieve a 30% improvement in productivity through ribosome engineering.
Innovation Solution
Development of a novel Streptomyces filamentosus mutant strain, DKB108, with a daptomycin productivity 12 times higher than the wild-type strain, achieved through UV irradiation and NTG mutation, optimized for large-scale tank fermentation using specific medium conditions and culture parameters.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If wild-type Streptomyces filamentosus strains are used for daptomycin production, then the production process is simple, but the daptomycin productivity is low
Solution Approach 1:
The patent converts the harmful effect of UV radiation and chemical mutagens (which cause random mutations and potential cell death) into a beneficial outcome by selecting mutant strains with dramatically improved daptomycin productivity. The mutagenesis process, while risky, yields strains like DKB108 that produce 12 times more daptomycin than wild-type strains.
Solution Approach 2:
The patent applies parameter changes by modifying the genetic parameters of Streptomyces filamentosus through UV irradiation and NTG treatment. This changes the biochemical parameters of the strain, enabling it to produce significantly higher amounts of daptomycin under optimized fermentation conditions.
2Productivity
If ribosome engineering is used to improve daptomycin productivity, then productivity increases by about 30%, but the improvement is insufficient for commercial production
Solution Approach 1:
The patent uses mutagenesis to create genetic variations that accidentally lead to superior productivity. The random mutations from UV and NTG treatment inadvertently produce strains with enhanced biosynthetic capabilities, far exceeding the modest 30% improvement from targeted ribosome engineering.
Solution Approach 2:
The patent fundamentally changes the genetic parameters of the strain through mutagenesis, creating permanent genetic modifications that result in sustained high-level daptomycin production. This approach achieves a 12-fold increase in productivity compared to the limited 30% improvement from ribosome engineering.
3Productivity
If mutant strains are developed through UV irradiation and NTG mutation, then daptomycin productivity increases 12 times, but the mutation process is complex
Solution Approach 1:
The patent segments the strain development process into distinct stages: UV irradiation treatment, NTG mutation treatment, screening for daptomycin production, and optimization of fermentation conditions. This segmentation makes the complex mutagenesis process more manageable and systematic.
Solution Approach 2:
The patent systematically changes multiple parameters including UV dose, NTG concentration, incubation time, and medium composition to optimize the mutagenesis process and achieve maximum daptomycin productivity in the mutant strains.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The DKB108 strain enables high and stable daptomycin production, facilitating commercial production and providing a significant increase in antibiotic yield, addressing the limitations of wild-type strains and previous productivity enhancement methods.
Implementation Method 1
a streptomyces filamentosus mutant strain, DKB108, with a daptomycin productivity 12 times higher than that of the wild-type strain, achieved through UV irradiation and NTG mutation
Implementation Method 2
achieved through UV irradiation and NTG mutation
Implementation Method 3
optimized for large-scale tank fermentation using specific medium conditions and culture parameters
Data Source
AI summary
Provided are a novel streptomyces filamentosus strain with improved daptomycin productivity, and a method for producing daptomycin using the same.